Aqr Capital Management LLC Protagonist Therapeutics, Inc Transaction History

Aqr Capital Management LLC

$64.6 Billion
Q2 2024

A detailed history of Aqr Capital Management LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 25,055 shares of PTGX stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,055

Previous 81,007 69.07%

Holding current value

$1.19 Million

Previous $2.34 Million 62.95%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$24.66 - $34.8 $1.38 Million - $1.95 Million	-55,952 Reduced 69.07%	25,055 $868,000
Q1 2024 May 15, 2024	BUY	$21.79 - $32.15 $1.56 Million - $2.3 Million	71,665 Added 767.13%	81,007 $2.34 Million
Q4 2023 Feb 14, 2024	SELL	$14.05 - $23.44 $15,792 - $26,346	-1,124 Reduced 10.74%	9,342 $214,000
Q3 2023 Nov 14, 2023	SELL	$16.68 - $23.66 $10,892 - $15,449	-653 Reduced 5.87%	10,466 $174,000
Q2 2023 Aug 14, 2023	BUY	$18.02 - $29.36 $200,364 - $326,453	11,119 New	11,119 $307,000
Q4 2022 Feb 14, 2023	SELL	$7.36 - $11.17 $542,564 - $823,430	-73,718 Reduced 64.28%	40,970 $446,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $11.71 $901,447 - $1.34 Million	114,688 New	114,688 $967,000
Q1 2022 May 16, 2022	SELL	$23.34 - $36.08 $354,231 - $547,586	-15,177 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$17.63 - $37.1 $467,195 - $983,150	-26,500 Reduced 63.58%	15,177 $519,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $49.69 $195,143 - $748,778	15,069 Added 56.63%	41,677 $739,000
Q2 2021 Aug 16, 2021	SELL	$25.57 - $44.88 $96,629 - $169,601	-3,779 Reduced 12.44%	26,608 $1.19 Million
Q1 2021 May 17, 2021	BUY	$19.02 - $31.15 $132,455 - $216,928	6,964 Added 29.73%	30,387 $787,000
Q4 2020 Feb 16, 2021	BUY	$18.49 - $25.13 $11,519 - $15,655	623 Added 2.73%	23,423 $472,000
Q3 2020 Nov 16, 2020	BUY	$15.19 - $22.4 $346,332 - $510,719	22,800 New	22,800 $446,000
Q2 2020 Aug 17, 2020	SELL	$6.19 - $18.84 $70,237 - $213,777	-11,347 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.4 - $9.22 $61,236 - $104,554	-11,340 Reduced 49.98%	11,347 $80,000
Q3 2019 Nov 14, 2019	BUY	$9.41 - $16.56 $213,484 - $375,696	22,687 New	22,687 $272,000

Others Institutions Holding PTGX

# of Institutions

212

Shares Held

59.1M

Call Options Held

19K

Put Options Held

107K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.34B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Protagonist Therapeutics, Inc Transaction History